Staying Ahead: Legislative Update in Cell and Gene Therapy

Nick Meza will be presenting at the 2025 NASP Annual Meeting on September 14. His presentation titled, "Staying Ahead: Legislative Update in Cell and Gene Therapy," will address rapidly evolving federal and state regulations impacting the development, distribution and patient access to these groundbreaking treatments. With 43 FDA-approved cell and gene therapies in the U.S. and over 4,000 in development worldwide, the legal framework is racing to keep pace. This discussion will provide practical, business-focused insights for manufacturers, specialty pharmacies and other stakeholders navigating licensure, reimbursement, distribution and compliance challenges in this fast-moving space.